A Phase 3, Randomized, Double-Blind, Comparator-Controlled Study to Evaluate Safety, Tolerability, and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Allogeneic Hematopoietic Cell Transplant Recipients (PNEU-STEM)

Marissa Wilck, Oliver A. Cornely, Catherine Cordonnier, Juan Diego Velez, Per Ljungman, Johan Maertens, Dominik Selleslag, Kathleen M. Mullane, Samir Nabhan, Qiuxu Chen, Ron Dagan, Peter Richmond, Caroline Daus, Kateasha Geddie, Gretchen Tamms, Tina Sterling, Shrita M. Patel, Tulin Shekar, Luwy Musey, Ulrike K. Buchwald

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'A Phase 3, Randomized, Double-Blind, Comparator-Controlled Study to Evaluate Safety, Tolerability, and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Allogeneic Hematopoietic Cell Transplant Recipients (PNEU-STEM)'. Together they form a unique fingerprint.

Medicine & Life Sciences